Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) FCF Margin Growth (3y) (2022 - 2025)

Analysis

Evotec SE (EVO) FCF Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 175.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 345.00
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 718.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 400.00
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -1,644.00
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -12,458.00
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -506.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -2,673.00
10 VivoSim Labs 1.47 Mn 1.47 Mn - -1.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.67 Mn
Sep 30, 2025 2,028.00
Jun 30, 2025 -9,825.00
Mar 31, 2025 -6.47 Mn
Dec 31, 2024 4.04 Mn
Sep 30, 2024 430,469.00
Jun 30, 2024 2.28 Mn
Mar 31, 2024 -3,293.00
Dec 31, 2022 2.95 Mn